Targeting Oncogenic miR-181a-2-3p Inhibits Growth and Suppresses Cisplatin Resistance of Gastric Cancer
Lei Jin,1,* Xuemei Ma,2,* Nan Zhang,3 Qian Zhang,4 Xueming Chen,1 Zhongtao Zhang,2 Guoqian Ding,2 Hongzhi Yu1 1Department of Vascular Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, People’s Republic of China; 2Department of General Surgery, Beijing Friends...
Guardado en:
Autores principales: | Jin L, Ma X, Zhang N, Zhang Q, Chen X, Zhang Z, Ding G, Yu H |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0cbf7869a16046459ab5bd7b0924d476 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The diagnostic and prognostic value of miR-92a in gastric cancer: A systematic review and meta-analysis
por: Guo Hanxu, et al.
Publicado: (2021) -
Bioinformatics Analysis of Hub Genes and Potential Therapeutic Agents Associated with Gastric Cancer
por: Zhang S, et al.
Publicado: (2021) -
Cisplatin-resistant lung cancer cell–derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100–5p-dependent manner
por: Qin X, et al.
Publicado: (2017) -
miR-299-3p suppresses cell progression and induces apoptosis by downregulating PAX3 in gastric cancer
por: Wang Zhenfen, et al.
Publicado: (2021) -
Downregulation of miR-135b-5p Suppresses Progression of Esophageal Cancer and Contributes to the Effect of Cisplatin
por: Yuzhu Di, et al.
Publicado: (2021)